Drag a card by its title · ⚙ to size, swap or remove

The company

Voyager Therapeutics, Inc.

VYGR · Nasdaq

Health CareBiotechnologyNot moving yet

VYGR stood above a rising 150-day average in 16 of the last 52 weekly readings, and has been out of that trend for the last 26 weeks. It is 40.2% below that average now. Biotechnology: 16% of its 561 stocks in an uptrend (−15 points in four weeks); Health Care: 26% (−10 points in four weeks).

SEC filings

Statistics

Rotation: Not moving yet
Weeks in an uptrend: out for 26
Industry in uptrend: 16% -15 in 4 wk
Insider buys, 12 months: $0
Insider sales, 12 months: $596K
Officials’ trades on record: 0
Institutions holding: 169 (+10)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 16 of 52 weeks.

20 Apr – 19 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0

Sale orders, 12 months11

Buyers · sellers0 · 4

Who	Did	Shares	Traded
Alfred SandrockPresident and CEO	sold	11,511at $3.87	2 Apr 2026filed 3 Apr 2026
Todd Alfred CarterChief Scientific Officer	sold	4,174at $3.76	24 Feb 2026filed 26 Feb 2026
Nathan D. JorgensenChief Financial Officer	sold	4,668at $3.77	24 Feb 2026filed 26 Feb 2026
Alfred SandrockPresident and CEO	sold	14,197at $3.79	24 Feb 2026filed 26 Feb 2026
Robin SwartzCOO & CBO	sold	6,458at $3.77	24 Feb 2026filed 26 Feb 2026
Alfred SandrockPresident and CEO	sold	11,732at $3.41	18 Feb 2026filed 20 Feb 2026
Todd Alfred CarterChief Scientific Officer	sold	3,301at $3.44	18 Feb 2026filed 20 Feb 2026
Robin SwartzCOO & CBO	sold	3,882at $3.44	18 Feb 2026filed 20 Feb 2026
Todd Alfred CarterChief Scientific Officer	sold	3,525at $3.85	10 Feb 2026filed 11 Feb 2026
Alfred SandrockPresident and CEO	sold	12,192at $3.78	10 Feb 2026filed 11 Feb 2026
Robin SwartzCOO & CBO	sold	4,569at $3.85	10 Feb 2026filed 11 Feb 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders169+10 on the quarter

New · exited29 · 19

Reported value$126.3M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
BlackRock, Inc.reduced · filed 7 Aug 2026	5,281,480$19.0M	-389,697−6.9%
MILLENNIUM MANAGEMENT LLCadded · filed 14 Aug 2026	4,442,951$15.6M	+1,014,380+29.6%
ARMISTICE CAPITAL, LLCreduced · filed 14 Aug 2026	3,436,000$12.0M	-361,706−9.5%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026	2,646,966$10.6M	+99,663+3.9%
Vestal Point Capital, LPreduced · filed 14 Aug 2026	2,625,000$9.2M	-377,936−12.6%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026	1,330,492$4.7M	+280,514+26.7%
Opaleye Management Inc.added · filed 14 Aug 2026	1,185,000$4.1M	+35,000+3.0%
STATE STREET CORPadded · filed 7 Aug 2026	1,111,798$4.0M	+128,196+13.0%
TWO SIGMA INVESTMENTS, LPadded · filed 14 Aug 2026	948,517$3.3M	+332,857+54.1%
DIMENSIONAL FUND ADVISORS LPreduced · filed 11 Aug 2026	838,184$2.9M	-37,384−4.3%